Examining Profiles and Treatment Outcomes in Dual Diagnosis: Comparison of Coordinated Treatment With Mental Health Services Versus Addiction Center Alone. A Real-World Data Analysis

References

• Arias, F., Szerman, N., Vega, P., Mesias, B., Basurte, I., Morant, C., Ochoa, E., Poyo, F., & Babín, F. (2013). Estudio Madrid sobre prevalencia y características de los pacientes con patología dual en tratamiento en las redes de salud mental y de atención al drogodependiente. Adicciones, 25(2), 118–127. https://doi.org/10.20882/adicciones.59
   PubMedGoogle Scholar
• Athanassiou, M., Dumais, A., Gnanhoue, G., Abdel-Baki, A., Jutras-Aswad, D., & Potvin, S. (2021). A systematic review of longitudinal studies investigating the impact of cannabis use in patients with psychotic disorders. Expert Review of Neurotherapeutics, 21(7), 779–791. https://doi.org/10.1080/14737175.2021.1942845
   PubMed Web of Science ®Google Scholar
• Balhara, Y. P. S., Lev-Ran, S., Martínez-Raga, J., Benyamina, A., Singh, S., Blecha, L., & Szerman, N. (2016). State of training, clinical services, and research on dual disorders across France, India, Israel, and Spain. Journal of Dual Diagnosis, 12(3–4), 252–260. https://doi.org/10.1080/15504263.2016.1254309
   PubMed Web of Science ®Google Scholar
• Benjet, C., Borges, G., Orozco, R., Aguilar-Gaxiola, S., Andrade, L. H., Cia, A., Hwang, I., Kessler, R. C., Piazza, M., Posada-Villa, J., Sampson, N., Stagnaro, J. C., Torres, Y., Viana, M. C., Vigo, D., & Medina-Mora, M.-E. (2022). Dropout from treatment for mental disorders in six countries of the Americas: A regional report from the World Mental Health Surveys. Journal of Affective Disorders, 303, 168–179. https://doi.org/10.1016/j.jad.2022.02.019
   PubMed Web of Science ®Google Scholar
• Brewer, S., Godley, M. D., & Hulvershorn, L. A. (2017). Treating mental health and substance use disorders in adolescents: What is on the menu? Current Psychiatry Reports, 19(1), 5. https://doi.org/10.1007/s11920-017-0755-0
   PubMed Web of Science ®Google Scholar
• Brooner, R. K., Kidorf, M. S., King, V. L., Peirce, J., Neufeld, K., Stoller, K., & Kolodner, K. (2013). Managing psychiatric comorbidity within versus outside of methadone treatment settings: A randomized and controlled evaluation. Addiction (Abingdon, England), 108(11), 1942–1951. https://doi.org/10.1111/add.12269
   PubMed Web of Science ®Google Scholar
• Buckner, J. D., Zvolensky, M. J., Ecker, A. H., Schmidt, N. B., Lewis, E. M., Paulus, D. J., Lopez-Gamundi, P., Crapanzano, K. A., & Bakhshaie, J. (2019). Integrated cognitive behavioral therapy for comorbid cannabis use and anxiety disorders: A pilot randomized controlled trial. Behaviour Research and Therapy, 115, 38–45. https://doi.org/10.1016/j.brat.2018.10.014
   PubMed Web of Science ®Google Scholar
• Castillo-Carniglia, A., Keyes, K. M., Hasin, D. S., & Cerdá, M. (2019). Psychiatric comorbidities in alcohol use disorder. The Lancet. Psychiatry, 6(12), 1068–1080. https://doi.org/10.1016/S2215-0366(19)30222-6
   PubMed Web of Science ®Google Scholar
• Cavalera, C., Ferrari, C., Bianconi, G., Bulgari, V., Candini, V., Carrà, G., Clerici, M., Conte, G., Cricelli, M., Ferla, M. T., Iozzino, L., Macis, A., Stefana, A., Ornaghi, A., & de Girolamo, G, & VIORMED-2 Group. (2020). Substance use disorders and violent behaviour in patients with severe mental disorders: A prospective, multicentre study. The Australian and New Zealand Journal of Psychiatry, 54(12), 1212–1223. https://doi.org/10.1177/0004867420963732
   PubMed Web of Science ®Google Scholar
• Chatterji, P., Alegria, M., & Takeuchi, D. (2011). Psychiatric disorders and labor market outcomes: Evidence from the national comorbidity survey-replication. Journal of Health Economics, 30(5), 858–868. https://doi.org/10.1016/j.jhealeco.2011.06.006
   PubMed Web of Science ®Google Scholar
• Clark, A. E., Goodwin, S. R., Marks, R. M., Belcher, A. M., Heinlein, E., Bennett, M. E., & Roche, D. J. O. (2021). A narrative literature review of the epidemiology, etiology, and treatment of co-occurring panic disorder and opioid use disorder. Journal of Dual Diagnosis, 17(4), 313–332. https://doi.org/10.1080/15504263.2021.1965407
   PubMed Web of Science ®Google Scholar
• Cohen, J. (1988). Statistical power analysis for the behavioral sciences. Routledge. https://doi.org/10.4324/9780203771587
   Google Scholar
• Dacosta-Sánchez, D., Díaz-Batanero, C., Fernandez-Calderon, F., & Lozano, Ó. M. (2021). Impact of Cluster B personality disorders in drugs therapeutic community treatment outcomes: A study based on real world data. Journal of Clinical Medicine, 10(12), 2572. https://doi.org/10.3390/jcm10122572
   PubMed Web of Science ®Google Scholar
• Dacosta-Sánchez, D., González-Ponce, B. M., Fernández-Calderón, F., Sánchez-García, M., & Lozano, O. M. (2022). Retention in treatment and therapeutic adherence: How are these associated with therapeutic success? An analysis using real-world data. International Journal of Methods in Psychiatric Research, 31(4), e1929. https://doi.org/10.1002/mpr.1929
   PubMed Web of Science ®Google Scholar
• Daigre, C., Grau-López, L., Palma-Alvarez, R. F., Perea-Ortueta, M., Sorribes-Puertas, M., Serrano-Pérez, P., Quesada, M., Segura, L., Coronado, M., Ramos-Quiroga, J. A., & Colom, J, & XAD-COVID19-Group. (2022). A multicenter study on the impact of gender, age, and dual diagnosis on substance consumption and mental health status in outpatients treated for substance use disorders during COVID-19 lockdown. Journal of Dual Diagnosis, 18(2), 71–80. https://doi.org/10.1080/15504263.2022.2051110
   PubMed Web of Science ®Google Scholar
• Daigre, C., Perea-Ortueta, M., Berenguer, M., Esculies, O., Sorribes-Puertas, M., Palma-Alvarez, R., Martínez-Luna, N., Ramos-Quiroga, J. A., & Grau-López, L. (2019). Psychiatric factors affecting recovery after a long term treatment program for substance use disorder. Psychiatry Research, 276, 283–289. https://doi.org/10.1016/j.psychres.2019.05.026
   PubMed Web of Science ®Google Scholar
• Daigre, C., Rodríguez, L., Roncero, C., Palma-Álvarez, R. F., Perea-Ortueta, M., Sorribes-Puertas, M., Martínez-Luna, N., Ros-Cucurull, E., Ramos-Quiroga, J. A., & Grau-López, L. (2021). Treatment retention and abstinence of patients with substance use disorders according to addiction severity and psychiatry comorbidity: A six-month follow-up study in an outpatient unit. Addictive Behaviors, 117, 106832. https://doi.org/10.1016/j.addbeh.2021.106832
   PubMed Web of Science ®Google Scholar
• Davis, J. P., Eddie, D., Prindle, J., Dworkin, E. R., Christie, N. C., Saba, S., DiGuiseppi, G. T., Clapp, J. D., & Kelly, J. F. (2021). Sex differences in factors predicting post-treatment opioid use. Addiction (Abingdon, England), 116(8), 2116–2126. https://doi.org/10.1111/add.15396
   PubMed Web of Science ®Google Scholar
• Del Río-Noriega, F., Castellano-Ramírez, J., Fernández-Burgos, F., Fernández-Gutiérrez, B., Guerra-Arévalo, J., Huizing, E., Lara-Ruiz-Granados, I., López-Álvarez, M., Martínez-García de Castro, M., Moreno-Pérez, A., Rojas-Corrales, M. O., Sanz-Amores, R., & Vázquez-Morejón, A. J. (2020). Trastorno mental grave. Consejería de Salud y Familias.
   Google Scholar
• Diby, A. S., Lengagne, P., & Regaert, C. (2021). Employment vulnerability of people with severe mental illness. Health Policy (Amsterdam, Netherlands), 125(2), 269–275. https://doi.org/10.1016/j.healthpol.2020.10.008
   PubMed Web of Science ®Google Scholar
• Dirección General de Asistencia Sanitaria (DGAS) & Dirección General de Servicios Sociales y Atención a las Drogodependencias (DGSSAD). (2012). Protocolo de actuación conjunta entre unidades de salud mental comunitaria y centros de tratamiento ambulatorio de drogodependencias. Servicio Andaluz de Salud.
   Google Scholar
• Drake, R. E., O'Neal, E. L., & Wallach, M. A. (2008). A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. Journal of Substance Abuse Treatment, 34(1), 123–138. https://doi.org/10.1016/j.jsat.2007.01.011
   PubMed Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction (2012). Treatment demand indicator (TDI) Standard protocol 3.0: Guidelines for reporting data on people entering drug treatment in European countries. EMCDDA.
   Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction (EMCCDA). (2022). European Drug Report 2022: Trends and development. Publications Office of the European Union. https://www.emcdda.europa.eu/system/files/publications/14644/20222419_TDAT22001ESN_PDF.pdf
   Google Scholar
• Fantuzzi, C., & Mezzina, R. (2020). Dual diagnosis: A systematic review of the organization of community health services. The International Journal of Social Psychiatry, 66(3), 300–310. https://doi.org/10.1177/0020764019899975
   PubMed Web of Science ®Google Scholar
• Fernández-Miranda, J. J., Fontoba-Díaz, J., Díaz-Fernández, S., & Pascual-Pastor, F. (2021). Concurrencia de trastorno por consumo de sustancias y de otro trastorno mental en personas en tratamiento por alguno de ellos en España. Adicciones, 1692. https://doi.org/10.20882/adicciones.1692
   PubMedGoogle Scholar
• Fleury, M.-J., Djouini, A., Huỳnh, C., Tremblay, J., Ferland, F., Ménard, J.-M., & Belleville, G. (2016). Remission from substance use disorders: A systematic review and meta-analysis. Drug and Alcohol Dependence, 168, 293–306. https://doi.org/10.1016/j.drugalcdep.2016.08.625
   PubMed Web of Science ®Google Scholar
• García-Marchena, N., Ladrón de Guevara-Miranda, D., Pedraz, M., Araos, P. F., Rubio, G., Ruiz, J. J., Pavón, F. J., Serrano, A., Castilla-Ortega, E., Santín, L. J., & Rodríguez de Fonseca, F. (2018). Higher impulsivity as a distinctive trait of severe cocaine addiction among individuals treated for cocaine or alcohol use disorders. Frontiers in Psychiatry, 9, 26. https://doi.org/10.3389/fpsyt.2018.00026
   PubMed Web of Science ®Google Scholar
• Ghabrash, M. F., Bahremand, A., Veilleux, M., Blais-Normandin, G., Chicoine, G., Sutra-Cole, C., Kaur, N., Ziegler, D., Dubreucq, S., Juteau, L.-C., Lestage, L., & Jutras-Aswad, D. (2020). Depression and outcomes of methadone and buprenorphine treatment among people with opioid use disorders: A literature review. Journal of Dual Diagnosis, 16(2), 191–207. https://doi.org/10.1080/15504263.2020.1726549
   PubMed Web of Science ®Google Scholar
• Gobbicchi, C., Verdolini, N., Menculini, G., Cirimbilli, F., Gallucci, D., Vieta, E., & Tortorella, A. (2021). Searching for factors associated with the “revolving door phenomenon” in the psychiatric inpatient unit: A 5-year retrospective cohort study. Psychiatry Research, 303(114080), 114080. https://doi.org/10.1016/j.psychres.2021.114080
   PubMedGoogle Scholar
• Greve, J., & Nielsen, L. H. (2013). Useful beautiful minds-an analysis of the relationship between schizophrenia and employment. Journal of Health Economics, 32(6), 1066–1076. https://doi.org/10.1016/j.jhealeco.2013.08.007
   PubMed Web of Science ®Google Scholar
• Hasin, D., & Walsh, C. (2020). Cannabis use, cannabis use disorder, and comorbid psychiatric illness: A narrative review. Journal of Clinical Medicine, 10(1), 15. https://doi.org/10.3390/jcm10010015
   PubMed Web of Science ®Google Scholar
• Hedges, L. V. (1981). Distribution theory for Glass’s estimator of effect size and related estimators. Journal of Educational Statistics, 6(2), 107–128. https://doi.org/10.3102/10769986006002107
   Google Scholar
• Hobden, B., Bryant, J., Carey, M., Baker, A. L., Farrell, M., Oldmeadow, C., Mattick, R. P., Shakeshaft, A., & Sanson-Fisher, R. (2018). Finding the optimal treatment model: A systematic review of treatment for co-occurring alcohol misuse and depression. The Australian and New Zealand Journal of Psychiatry, 52(8), 737–750. https://doi.org/10.1177/0004867418758922
   PubMed Web of Science ®Google Scholar
• Høye, A., Jacobsen, B. K., Bramness, J. G., Nesvåg, R., Reichborn-Kjennerud, T., & Heiberg, I. (2021). Total and cause-specific mortality in patients with personality disorders: the association between comorbid severe mental illness and substance use disorders. Social Psychiatry and Psychiatric Epidemiology, 56(10), 1809–1819. https://doi.org/10.1007/s00127-021-02055-3
   PubMed Web of Science ®Google Scholar
• Hunt, G. E., Large, M. M., Cleary, M., Lai, H. M. X., & Saunders, J. B. (2018). Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990–2017: Systematic review and meta-analysis. Drug and Alcohol Dependence, 191, 234–258. https://doi.org/10.1016/j.drugalcdep.2018.07.011
   PubMed Web of Science ®Google Scholar
• Hunt, G. E., Malhi, G. S., Lai, H. M. X., & Cleary, M. (2020). Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990–2019: Systematic review and meta-analysis. Journal of Affective Disorders, 266, 288–304. https://doi.org/10.1016/j.jad.2020.01.141
   PubMed Web of Science ®Google Scholar
• Jones, M., Guirguis, A., Watkins, A., Bradshaw, C., Mohamed, L., & Schifano, F. (2023). Obstacles to treatment retention in opioid use disorder: An international substance use disorder treatment worker survey. Human Psychopharmacology, 38(5), e2882. https://doi.org/10.1002/hup.2882
   PubMed Web of Science ®Google Scholar
• Karapareddy, V. (2019). A review of integrated care for concurrent disorders: Cost effectiveness and clinical outcomes. Journal of Dual Diagnosis, 15(1), 56–66. https://doi.org/10.1080/15504263.2018.1518553
   PubMed Web of Science ®Google Scholar
• Karpyak, V. M., Biernacka, J. M., Geske, J. R., Abulseoud, O. A., Brunner, M. D., Chauhan, M., Hall-Flavin, D. K., Lewis, K. A., Loukianova, L. L., Melnyk, G. J., Onsrud, D. A., Proctor, B. D., Schneekloth, T. D., Skime, M. K., Wittkopp, J. E., Frye, M. A., & Mrazek, D. A. (2016). Gender‐specific effects of comorbid depression and anxiety on the propensity to drink in negative emotional states: Gender-specific negative craving. Addiction (Abingdon, England), 111(8), 1366–1375. https://doi.org/10.1111/add.13386
   PubMed Web of Science ®Google Scholar
• Krawczyk, N., Feder, K. A., Saloner, B., Crum, R. M., Kealhofer, M., & Mojtabai, R. (2017). The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample. Drug and Alcohol Dependence, 175, 157–163. https://doi.org/10.1016/j.drugalcdep.2017.02.006
   PubMed Web of Science ®Google Scholar
• Lai, H. M. X., Cleary, M., Sitharthan, T., & Hunt, G. E. (2015). Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A systematic review and meta-analysis. Drug and Alcohol Dependence, 154, 1–13. https://doi.org/10.1016/j.drugalcdep.2015.05.031
   PubMed Web of Science ®Google Scholar
• Lee, D. C., Schlienz, N. J., Peters, E. N., Dworkin, R. H., Turk, D. C., Strain, E. C., & Vandrey, R. (2019). Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder. Drug and Alcohol Dependence, 194, 500–517. https://doi.org/10.1016/j.drugalcdep.2018.10.020
   PubMed Web of Science ®Google Scholar
• Lowe, D. J. E., Sasiadek, J. D., Coles, A. S., & George, T. P. (2019). Cannabis and mental illness: A review. European Archives of Psychiatry and Clinical Neuroscience, 269(1), 107–120. https://doi.org/10.1007/s00406-018-0970-7
   PubMed Web of Science ®Google Scholar
• Makady, A., de Boer, A., Hillege, H., Klungel, O., & Goettsch, W, & (on behalf of GetReal Work Package 1). (2017). What is real-world data? A review of definitions based on literature and stakeholder interviews. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 20(7), 858–865. https://doi.org/10.1016/j.jval.2017.03.008
   PubMed Web of Science ®Google Scholar
• Mancheño, J. J., Navas-León, S., Fernández-Calderón, F., Gutiérrez, M., Sánchez-García, M., Díaz-Batanero, C., Moraleda-Barreno, E., Ramírez-López, J., Lorca, J. A., & Lozano Rojas, O. M. (2021). Coordinated treatment between addiction and mental health services vs. uncoordinated treatment for patients with dual diagnosis: higher dropout rates but lower impairement of functional disability. Actas espanolas de psiquiatria, 49(2), 71–80. https://europepmc.org/article/MED/33686639
   PubMed Web of Science ®Google Scholar
• Maniaci, G., La Cascia, C., Picone, F., Lipari, A., Cannizzaro, C., & La Barbera, D. (2017). Predictors of early dropout in treatment for gambling disorder: The role of personality disorders and clinical syndromes. Psychiatry Research, 257, 540–545. https://doi.org/10.1016/j.psychres.2017.08.003
   PubMed Web of Science ®Google Scholar
• Marsch, L. A., Campbell, A., Campbell, C., Chen, C.-H., Ertin, E., Ghitza, U., Lambert-Harris, C., Hassanpour, S., Holtyn, A. F., Hser, Y.-I., Jacobs, P., Klausner, J. D., Lemley, S., Kotz, D., Meier, A., McLeman, B., McNeely, J., Mishra, V., Mooney, L., … Young, S. (2020). The application of digital health to the assessment and treatment of substance use disorders: The past, current, and future role of the National Drug Abuse Treatment Clinical Trials Network. Journal of Substance Abuse Treatment, 112S, 4–11. https://doi.org/10.1016/j.jsat.2020.02.005
   PubMedGoogle Scholar
• Matali, J. L., Andión, O., Pardo, M., Iniesta, R., Serrano, E., & San, L. (2016). Adolescents and dual diagnosis in a psychiatric emergency service. Adicciones, 28(2), 71–79. https://doi.org/10.20882/adicciones.783
   PubMed Web of Science ®Google Scholar
• McGovern, M. P., Saunders, E. C., & Kim, E. (2013). Substance abuse treatment implementation research. Journal of Substance Abuse Treatment, 44(1), 1–3. https://doi.org/10.1016/j.jsat.2012.09.006
   PubMed Web of Science ®Google Scholar
• Merkouris, S. S., Thomas, S. A., Browning, C. J., & Dowling, N. A. (2016). Predictors of outcomes of psychological treatments for disordered gambling: A systematic review. Clinical Psychology Review, 48, 7–31. https://doi.org/10.1016/j.cpr.2016.06.004
   PubMed Web of Science ®Google Scholar
• Messer, T., Lammers, G., Müller-Siecheneder, F., Schmidt, R.-F., & Latifi, S. (2017). Substance abuse in patients with bipolar disorder: A systematic review and meta-analysis. Psychiatry Research, 253, 338–350. https://doi.org/10.1016/j.psychres.2017.02.067
   PubMed Web of Science ®Google Scholar
• Milward, J., Lynskey, M., & Strang, J. (2014). Solving the problem of non-attendance in substance abuse services: Solving the problem of non-attendance. Drug and Alcohol Review, 33(6), 625–636. https://doi.org/10.1111/dar.12194
   PubMed Web of Science ®Google Scholar
• Miquel, L., Roncero, C., López-Ortiz, C., & Casas, M. (2011). Diferencias de género epidemiológicas y diagnósticas según eje I en pacientes con Patología Dual. Adicciones, 23(2), 165. https://doi.org/10.20882/adicciones.160
   PubMed Web of Science ®Google Scholar
• Molina, B. S. G., & Pelham, W. E. (2014). Attention-deficit/hyperactivity disorder and risk of substance use disorder: Developmental considerations, potential pathways, and opportunities for research. Annual Review of Clinical Psychology, 10(1), 607–639. https://doi.org/10.1146/annurev-clinpsy-032813-153722
   PubMedGoogle Scholar
• Mougharbel, F., Sampasa-Kanyinga, H., Heidinger, B., Corace, K., Hamilton, H. A., & Goldfield, G. S. (2021). Psychological and demographic determinants of substance use and mental health during the COVID-19 pandemic. Frontiers in Public Health, 9, 680028. https://doi.org/10.3389/fpubh.2021.680028
   PubMed Web of Science ®Google Scholar
• Mulder, R. T., Frampton, C. M. A., Peka, H., Hampton, G., & Marsters, T. (2009). Predictors of 3-month retention in a drug treatment therapeutic community: Predictors of 3-month retention. Drug and Alcohol Review, 28(4), 366–371. https://doi.org/10.1111/j.1465-3362.2009.00050.x
   PubMed Web of Science ®Google Scholar
• Murrie, B., Lappin, J., Large, M., & Sara, G. (2020). Transition of substance-induced, brief, and atypical psychoses to schizophrenia: A systematic review and meta-analysis. Schizophrenia Bulletin, 46(3), 505–516. https://doi.org/10.1093/schbul/sbz102
   PubMed Web of Science ®Google Scholar
• Murthy, P., Mahadevan, J., & Chand, P. K. (2019). Treatment of substance use disorders with co-occurring severe mental health disorders. Current Opinion in Psychiatry, 32(4), 293–299. https://doi.org/10.1097/YCO.0000000000000510
   PubMed Web of Science ®Google Scholar
• National Institute on Drug Abuse (NIDA). (2018). Principles of drug addiction treatment: A research-based guide (3rd ed.). Createspace Independent Publishing Platform.
   Google Scholar
• Newton-Howes, G. M., Foulds, J. A., Guy, N. H., Boden, J. M., & Mulder, R. T. (2017). Personality disorder and alcohol treatment outcome: Systematic review and meta-analysis. The British Journal of Psychiatry: The Journal of Mental Science, 211(1), 22–30. https://doi.org/10.1192/bjp.bp.116.194720
   PubMed Web of Science ®Google Scholar
• Oliva, F., Mangiapane, C., Nibbio, G., Berchialla, P., Colombi, N., & Vigna-Taglianti, F. D. (2021). Prevalence of cocaine use and cocaine use disorder among adult patients with attention-deficit/hyperactivity disorder: A systematic review and meta-analysis. Journal of Psychiatric Research, 143, 587–598. https://doi.org/10.1016/j.jpsychires.2020.11.021
   PubMed Web of Science ®Google Scholar
• Petrakis, M., Robinson, R., Myers, K., Kroes, S., & O’Connor, S. (2018). Dual diagnosis competencies: A systematic review of staff training literature. Addictive Behaviors Reports, 7, 53–57. https://doi.org/10.1016/j.abrep.2018.01.003
   PubMedGoogle Scholar
• Phelan, S., & Sigala, N. (2022). The effect of treatment on insight in psychotic disorders - A systematic review and meta-analysis. Schizophrenia Research, 244, 126–133. https://doi.org/10.1016/j.schres.2022.05.023
   PubMed Web of Science ®Google Scholar
• Ries, R. K. (1992). Serial, parallel, and integrated models of dual-diagnosis treatment. Journal of Health Care for the Poor and Underserved, 3(1), 173–180. https://doi.org/10.1353/hpu.2010.0283
   PubMedGoogle Scholar
• Roncero, C., Palma-Álvarez, R. F., Díaz-Morán, S., Grau-López, L., Rodríguez-Cintas, L., Ros-Cucurull, E., Álvarez, A. I., Casas, M., & Daigre, C. (2019). Cocaine relapse and health-related quality of life: a 23 weeks study. Actas espanolas de psiquiatria, 47(2), 37–44.
   PubMed Web of Science ®Google Scholar
• Roncero, C., Szerman, N., Terán, A., Pino, C., Vázquez, J. M., Velasco, E., García-Dorado, M., & Casas, M. (2016). Professionals’ perception on the management of patients with dual disorders. Patient Preference and Adherence, 10, 1855–1868. https://doi.org/10.2147/PPA.S108678
   PubMed Web of Science ®Google Scholar
• Samuel, D. B., LaPaglia, D. M., Maccarelli, L. M., Moore, B. A., & Ball, S. A. (2011). Personality disorders and retention in a therapeutic community for substance dependence: Personality disorders predicting retention. The American Journal on Addictions, 20(6), 555–562. https://doi.org/10.1111/j.1521-0391.2011.00174.x
   PubMed Web of Science ®Google Scholar
• Sannibale, C., Teesson, M., Creamer, M., Sitharthan, T., Bryant, R. A., Sutherland, K., Taylor, K., Bostock-Matusko, D., Visser, A., & Peek-O’Leary, M. (2013). Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders: RCT of CBT for comorbid PTSD and AUD. Addiction (Abingdon, England), 108(8), 1397–1410. https://doi.org/10.1111/add.12167
   PubMed Web of Science ®Google Scholar
• Scoppetta, O., Avendaño Prieto, B. L., & Cassiani Miranda, C. (2020). Factores Individuales Asociados al Consumo de Sustancias Ilícitas: Una Revisión de Revisiones. Revista Colombiana de Psiquiatría (Psiquiatría), 51(3), 206–217. https://doi.org/10.1016/j.rcp.2020.01.007
   Google Scholar
• Sherman, B. J., McRae-Clark, A. L., Baker, N. L., Sonne, S. C., Killeen, T. K., Cloud, K., & Gray, K. M. (2017). Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study: ACCENT-Gender Differences and CUD. The American Journal on Addictions, 26(2), 136–144. https://doi.org/10.1111/ajad.12503
   PubMed Web of Science ®Google Scholar
• Silbernagl, M., Yanagida, T., Slamanig, R., Fischer, G., & Brandt, L. (2019). Comorbidity patterns among patients with opioid use disorder and problem gambling: ADHD status predicts class membership. Journal of Dual Diagnosis, 15(3), 147–158. https://doi.org/10.1080/15504263.2019.1590672
   PubMed Web of Science ®Google Scholar
• Sliedrecht, W., de Waart, R., Witkiewitz, K., & Roozen, H. G. (2019). Alcohol use disorder relapse factors: A systematic review. Psychiatry Research, 278, 97–115. https://doi.org/10.1016/j.psychres.2019.05.038
   PubMed Web of Science ®Google Scholar
• Sofer, M. M., Kaptsan, A., & Anson, J. (2018). Factors associated with unplanned early discharges from a dual diagnosis inpatient detoxification unit in Israel. Journal of Dual Diagnosis, 14(3), 137–147. https://doi.org/10.1080/15504263.2018.1461965
   PubMed Web of Science ®Google Scholar
• Starzer, M. S. K., Nordentoft, M., & Hjorthøj, C. (2018). Rates and predictors of conversion to schizophrenia or bipolar disorder following substance-induced psychosis. The American Journal of Psychiatry, 175(4), 343–350. https://doi.org/10.1176/appi.ajp.2017.17020223
   PubMed Web of Science ®Google Scholar
• Subramaniam, S., Yee, A., Bin Amer Nordin, A. S., & Bin Khalib, A. Q. (2021). Prevalence of severe mental illness dual diagnosis among inpatients in a psychiatric hospital in Malaysia. Journal of Dual Diagnosis, 17(1), 4–12. https://doi.org/10.1080/15504263.2020.1854410
   PubMed Web of Science ®Google Scholar
• Szerman, N., Parro-Torres, C., Didia-Attas, J., & El-Guebaly, N. (2019). Dual disorders: Addiction and other mental disorders. In A. Javed & K. Fountoulakis (Eds.), Integrating mental health. In Advances in Psychiatry (pp. 109–127). Springer International Publishing.
   Google Scholar
• Torrens, M., Mestre-Pintó, J.-I., & Domingo-Salvany, A, European Monitoring Centre for Drugs and Drug Addiction (EMCCDA), (2015). Comorbidity of substance use and mental disorders in Europe. Publications Office of the European Union.
   Google Scholar
• Tull, M. T., & Gratz, K. L. (2012). The impact of borderline personality disorder on residential substance abuse treatment dropout among men. Drug and Alcohol Dependence, 121(1-2), 97–102. https://doi.org/10.1016/j.drugalcdep.2011.08.014
   PubMed Web of Science ®Google Scholar
• Vergara-Moragues, E., & González-Saiz, F. (2020). Predictive outcome validity of general health questionnaire (GHQ-28) in substance abuse patients treated in therapeutic communities. Journal of Dual Diagnosis, 16(2), 218–227. https://doi.org/10.1080/15504263.2019.1674465
   PubMed Web of Science ®Google Scholar
• Vergara-Moragues, E., González-Saiz, F., Lozano, O. M., Betanzos Espinosa, P., Fernández Calderón, F., Bilbao-Acebos, I., Pérez García, M., & Verdejo García, A. (2012). Psychiatric comorbidity in cocaine users treated in therapeutic community: substance-induced versus independent disorders. Psychiatry Research, 200(2–3), 734–741. https://doi.org/10.1016/j.psychres.2012.07.043
   PubMed Web of Science ®Google Scholar
• Vergara-Moragues, E., González-Saiz, F., Lozano, O. M., & Verdejo García, A. (2013). Psychiatric profile of three-month retention in cocaine-dependent patients treated in a therapeutic community. Journal of Studies on Alcohol and Drugs, 74(3), 452–459. https://doi.org/10.15288/jsad.2013.74.452
   PubMed Web of Science ®Google Scholar
• Viera, A., Bromberg, D. J., Whittaker, S., Refsland, B. M., Stanojlović, M., Nyhan, K., & Altice, F. L. (2020). Adherence to and retention in medications for opioid use disorder among adolescents and young adults. Epidemiologic Reviews, 42(1), 41–56. https://doi.org/10.1093/epirev/mxaa001
   PubMed Web of Science ®Google Scholar
• Watkins, L. E., Patton, S. C., Drexler, K., Rauch, S. A. M., & Rothbaum, B. O. (2023). Clinical effectiveness of an intensive outpatient program for integrated treatment of comorbid substance abuse and mental health disorders. Cognitive and Behavioral Practice, 30(3), 354–366. https://doi.org/10.1016/j.cbpra.2022.05.005
   Web of Science ®Google Scholar
• World Health Organization (2003). Adherence to long-term therapies: Evidence for action. World Health Organization.
   Google Scholar